Kevin Retailleau

1.5k total citations
18 papers, 1.1k citations indexed

About

Kevin Retailleau is a scholar working on Physiology, Molecular Biology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Kevin Retailleau has authored 18 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Physiology, 6 papers in Molecular Biology and 6 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Kevin Retailleau's work include Nitric Oxide and Endothelin Effects (5 papers), Genetic and Kidney Cyst Diseases (4 papers) and Renin-Angiotensin System Studies (4 papers). Kevin Retailleau is often cited by papers focused on Nitric Oxide and Endothelin Effects (5 papers), Genetic and Kidney Cyst Diseases (4 papers) and Renin-Angiotensin System Studies (4 papers). Kevin Retailleau collaborates with scholars based in France, United States and Germany. Kevin Retailleau's co-authors include Fabrice Duprat, Laurent Loufrani, Stefan Offermanns, Martine Jodar, Amanda Patel, Malika Arhatte, Éric Honoré, Daniel Henrion, Sophie Demolombe and Yuanyi Feng and has published in prestigious journals such as Cell, Nature Medicine and Circulation Research.

In The Last Decade

Kevin Retailleau

18 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kevin Retailleau France 13 589 435 196 192 181 18 1.1k
Angela Wirth Germany 15 856 1.5× 327 0.8× 285 1.5× 104 0.5× 72 0.4× 26 1.4k
Harmandeep Kaur Germany 15 716 1.2× 443 1.0× 261 1.3× 245 1.3× 44 0.2× 32 1.3k
Marcel Liberman Brazil 12 343 0.6× 132 0.3× 168 0.9× 124 0.6× 99 0.5× 19 1.1k
Nupur B. Dey United States 15 557 0.9× 416 1.0× 272 1.4× 107 0.6× 58 0.3× 19 992
Aiji Sakamoto Japan 18 608 1.0× 296 0.7× 395 2.0× 95 0.5× 64 0.4× 40 1.0k
Julián Albarrán-Juárez Germany 17 804 1.4× 360 0.8× 132 0.7× 292 1.5× 26 0.1× 21 1.4k
Matthew Hayden United Kingdom 5 826 1.4× 89 0.2× 97 0.5× 80 0.4× 511 2.8× 5 1.4k
Jason Xu United States 13 859 1.5× 142 0.3× 109 0.6× 154 0.8× 45 0.2× 23 1.1k
A. Lepple-Wienhues Germany 18 843 1.4× 239 0.5× 139 0.7× 73 0.4× 32 0.2× 23 1.3k
Jean Verdetti France 16 331 0.6× 169 0.4× 125 0.6× 84 0.4× 220 1.2× 43 897

Countries citing papers authored by Kevin Retailleau

Since Specialization
Citations

This map shows the geographic impact of Kevin Retailleau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kevin Retailleau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kevin Retailleau more than expected).

Fields of papers citing papers by Kevin Retailleau

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kevin Retailleau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kevin Retailleau. The network helps show where Kevin Retailleau may publish in the future.

Co-authorship network of co-authors of Kevin Retailleau

This figure shows the co-authorship network connecting the top 25 collaborators of Kevin Retailleau. A scholar is included among the top collaborators of Kevin Retailleau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kevin Retailleau. Kevin Retailleau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Retailleau, Kevin, et al.. (2024). A Novel Catalytically Inactive Construct of Botulinum Neurotoxin A (BoNT/A) Directly Inhibits Visceral Sensory Signalling. Toxins. 16(1). 30–30. 1 indexed citations
2.
3.
Martin, Vincent, Kevin Retailleau, Stéphane Lezmi, et al.. (2022). BoNT/A1 Secondary Failure for the Treatment of Neurogenic Detrusor Overactivity: An Ex Vivo Functional Study. Toxins. 14(2). 77–77. 2 indexed citations
4.
Retailleau, Kevin, Malika Arhatte, Sophie Demolombe, et al.. (2016). Arterial Myogenic Activation through Smooth Muscle Filamin A. Cell Reports. 14(9). 2050–2058. 26 indexed citations
5.
Retailleau, Kevin, Malika Arhatte, Sophie Demolombe, et al.. (2016). Smooth muscle filamin A is a major determinant of conduit artery structure and function at the adult stage. Pflügers Archiv - European Journal of Physiology. 468(7). 1151–1160. 22 indexed citations
6.
Retailleau, Kevin, Fabrice Duprat, Malika Arhatte, et al.. (2015). Piezo1 in Smooth Muscle Cells Is Involved in Hypertension-Dependent Arterial Remodeling. Cell Reports. 13(6). 1161–1171. 269 indexed citations
7.
Retailleau, Kevin & Fabrice Duprat. (2014). Polycystins and partners: proposed role in mechanosensitivity. The Journal of Physiology. 592(12). 2453–2471. 52 indexed citations
8.
André‐Grégoire, Gwennan, Juan E. Sandoval, Kevin Retailleau, et al.. (2014). Smooth Muscle Specific Rac1 Deficiency Induces Hypertension by Preventing p116 RIP 3 ‐Dependent RhoA Inhibition. Journal of the American Heart Association. 3(3). e000852–e000852. 27 indexed citations
9.
Labat, Carlos, Mathias Mericskay, Karima Ait‐Aissa, et al.. (2013). Inactivation of Serum Response Factor Contributes To Decrease Vascular Muscular Tone and Arterial Stiffness in Mice. Circulation Research. 112(7). 1035–1045. 34 indexed citations
10.
Retailleau, Kevin, Bertrand Toutain, Céline Fassot, et al.. (2012). Selective Involvement of Serum Response Factor in Pressure-Induced Myogenic Tone in Resistance Arteries. Arteriosclerosis Thrombosis and Vascular Biology. 33(2). 339–346. 12 indexed citations
11.
Guilluy, Christophe, Jérémy Brégeon, Gilles Toumaniantz, et al.. (2010). The Rho exchange factor Arhgef1 mediates the effects of angiotensin II on vascular tone and blood pressure. Nature Medicine. 16(2). 183–190. 191 indexed citations
12.
Duprat, Fabrice, Joost H.A. Folgering, Delphine Bichet, et al.. (2010). Polycystin‐1 and ‐2 Dosage Regulates Pressure Sensing. The FASEB Journal. 24(S1). 4 indexed citations
13.
Sharif‐Naeini, Reza, Joost H.A. Folgering, Delphine Bichet, et al.. (2009). Polycystin-1 and -2 Dosage Regulates Pressure Sensing. Cell. 139(3). 587–596. 262 indexed citations
14.
Retailleau, Kevin, Eric J. Belin de Chantemèle, Sébastien Chanoine, et al.. (2009). Reactive Oxygen Species and Cyclooxygenase 2-Derived Thromboxane A2 Reduce Angiotensin II Type 2 Receptor Vasorelaxation in Diabetic Rat Resistance Arteries. Hypertension. 55(2). 339–344. 34 indexed citations
15.
Loufrani, Laurent, Kevin Retailleau, Arnaud Bocquet, et al.. (2008). Key role of α1β1-integrin in the activation of PI3-kinase-Akt by flow (shear stress) in resistance arteries. American Journal of Physiology-Heart and Circulatory Physiology. 294(4). H1906–H1913. 35 indexed citations
16.
Chantemèle, Eric J. Belin de, Kevin Retailleau, Frédéric Pinaud, et al.. (2008). Notch3 Is a Major Regulator of Vascular Tone in Cerebral and Tail Resistance Arteries. Arteriosclerosis Thrombosis and Vascular Biology. 28(12). 2216–2224. 82 indexed citations
17.
Pinaud, Frédéric, Arnaud Bocquet, Odile Dumont, et al.. (2007). Paradoxical Role of Angiotensin II Type 2 Receptors in Resistance Arteries of Old Rats. Hypertension. 50(1). 96–102. 43 indexed citations
18.
Pinaud, Frédéric, Arnaud Bocquet, Odile Dumont, et al.. (2007). PARADOXICAL ROLE OF ANGIOTENSIN II TYPE 2 RECEPTORS IN RESISTANCE ARTERIES OF OLD RATS. The FASEB Journal. 21(6). 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Angela Wirth Breakdown of academic impact, for papers by Harmandeep Kaur Breakdown of academic impact, for papers by Marcel Liberman Breakdown of academic impact, for papers by Nupur B. Dey Breakdown of academic impact, for papers by Aiji Sakamoto Breakdown of academic impact, for papers by Julián Albarrán-Juárez Breakdown of academic impact, for papers by Matthew Hayden Breakdown of academic impact, for papers by Jason Xu Breakdown of academic impact, for papers by A. Lepple-Wienhues Breakdown of academic impact, for papers by Jean Verdetti
Rankless by CCL
2026